By evaluating the effect of RANTES on the MDA-MB-231 model BC cell line, we visualized patterns of CCR5 signaling (i.e., CCR5 pools, activation, and internalization) that are a mechanistic explanation for the CCR5 signaling present in primary biopsies and circulating TACs in breast cancer patients. The gene discussed is CCL5; the disease is breast carcinoma.